Establishment of an artificial urine model in vitro and rat or pig model in vivo to evaluate urinary crystal adherence

Kana Hayashi,Katsumi Shigemura,Hiroshi Tanimoto,Kazuo Kumagai,Ralph Rolly Gonzales,Young-Min Yang,Koki Maeda,Hideto Matsuyama,Masato Fujisawa
DOI: https://doi.org/10.1038/s41598-024-62766-w
IF: 4.6
2024-05-26
Scientific Reports
Abstract:The current study aimed to establish an experimental model in vitro and in vivo of urinary crystal deposition on the surface of ureteral stents, to evaluate the ability to prevent crystal adhesion. Non-treated ureteral stents were placed in artificial urine under various conditions in vitro. In vivo, ethylene glycol and hydroxyproline were administered orally to rats and pigs, and urinary crystals and urinary Ca were investigated by Inductively Coupled Plasma-Optical Emission Spectrometer. in vitro, during the 3- and 4-week immersion periods, more crystals adhered to the ureteral stent in artificial urine model 1 than the other artificial urine models (p < 0.01). Comparing the presence or absence of urea in the composition of the artificial urine, the artificial urine without urea showed less variability in pH change and more crystal adhesion (p < 0.05). Starting the experiment at pH 6.3 resulted in the highest amount of crystal adhesion to the ureteral stent (p < 0.05). In vivo, urinary crystals and urinary Ca increased in rat and pig experimental models. This experimental model in vitro and in vivo can be used to evaluate the ability to prevent crystal adhesion and deposition in the development of new ureteral stents to reduce ureteral stent-related side effects in patients.
multidisciplinary sciences
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to establish an in - vitro and in - vivo experimental model to evaluate the ability of urinary crystal deposition on the surface of ureteral stents. Specifically, the study aims to test the attachment of urinary crystals on the surface of ureteral stents under different conditions by simulating the human urine environment, thus providing an experimental basis for the development of new ureteral stents that can reduce ureteral stent - related side effects (such as pain, infection, hematuria and irritative bladder symptoms). ### Main research background: 1. **Clinical needs**: Urological patients, especially those with ureteral stones caused by ureteral stenosis or ureteral cancer, are prone to urinary tract obstruction or urinary stasis, which may lead to renal insufficiency. Ureteral stents are usually placed to ensure unobstructed urinary tract. However, long - term indwelling of ureteral stents may lead to foreign body or crystal deposition, causing urinary tract obstruction. 2. **Crystallization mechanism**: There are two main mechanisms for urinary crystals to attach to ureteral stents: one is bacteria - mediated, and the other is that the crystalline components in urine are directly deposited on the stent surface. - **Bacteria - mediated**: Proteins in urine are adsorbed on the stent surface, and bacteria use these proteins to form biofilms. Some urinary bacteria produce urease, which decomposes urea to produce ammonia. Ammonia increases the pH of urine, causing dissolved calcium to precipitate and form crystals. - **Direct deposition**: Due to excessive intake of calcium oxalate, the calcium concentration in urine increases, and calcium salts are directly precipitated on the surface of the ureteral stent without the participation of bacteria. ### Research methods: 1. **In - vitro experiment**: - Soak uncoated ureteral stents in artificial urine with three different components and observe the crystal attachment. - Compare the effects of artificial urine containing urea and without urea on crystal attachment. - Evaluate the crystal attachment under different initial pH conditions. 2. **In - vivo experiment**: - **Rat model**: Promote the formation of urinary crystals by oral administration of ethylene glycol and aminochloride, and observe the crystal attachment after placing the ureteral stent. - **Pig model**: Promote the formation of urinary crystals by oral administration of hydroxyproline, ethylene glycol and vitamin D, and observe the crystal attachment after placing the ureteral stent. ### Main findings: 1. **In - vitro experiment**: - In the artificial urine model 1, during the soaking periods of 3 weeks and 4 weeks, the amount of crystal attachment on the stent surface was significantly higher than that of other models (p < 0.01). - The pH change of artificial urine without urea was smaller, and the amount of crystal attachment was more (p < 0.05). - The artificial urine with an initial pH of 6.3 had the highest amount of crystal attachment during the 4 - week soaking period (p < 0.05). 2. **In - vivo experiment**: - In the rat and pig models, the crystal and calcium contents in urine increased. - Through scanning electron microscope (SEM) and energy - dispersive spectroscopy (EDS) analysis, the crystalline components on the stent surface were confirmed. ### Conclusion: This study successfully established in - vitro and in - vivo experimental models, which can be used to evaluate the ability of newly - designed ureteral stents to prevent crystal attachment and deposition. These models provide important experimental tools for the future development of more effective ureteral stents.